LA JOLLA, CA--(Marketwire - October 31, 2007) - Transdel Pharmaceuticals, Inc. (OTCBB: TDLP), a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically targeted medications, today announced that Dr. Juliet Singh, President and Chief Executive Officer, will present at the Rodman and Renshaw 9th Annual Healthcare Conference on Wednesday, November 7th at 3:00 p.m. Eastern Time at the New York Palace Hotel in Hubbard located on the 5th floor.
